$5.34
ESSA Pharma is a biotechnology business based in the US. ESSA Pharma shares (EPIX) are listed on the NASDAQ and all prices are listed in US Dollars. ESSA Pharma employs 50 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy ESSA Pharma stock
How to buy ESSA Pharma stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EPIX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy ESSA Pharma stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
ESSA Pharma stock price (NASDAQ: EPIX)
Use our graph to track the performance of EPIX stocks over time.ESSA Pharma shares at a glance
Latest market close | $5.42 |
---|---|
52-week range | $2.58 - $11.67 |
50-day moving average | $5.59 |
200-day moving average | $6.57 |
Wall St. target price | $19.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.63 |
Is it a good time to buy ESSA Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ESSA Pharma price performance over time
Historical closes compared with the close of $5.42 from 2024-07-25
1 week (2024-07-19) | 5.45% |
---|---|
1 month (2024-06-27) | 4.63% |
3 months (2024-04-26) | -10.86% |
6 months (2024-01-26) | -30.42% |
1 year (2023-07-27) | 89.51% |
---|---|
2 years (2022-07-27) | 87.54% |
3 years (2021-07-27) | 22.8 |
5 years (2019-07-26) | 104.53% |
ESSA Pharma financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -14.4% |
Return on equity TTM | -19.14% |
Profit margin | 0% |
Book value | $3.01 |
Market Capitalization | $228 million |
TTM: trailing 12 months
ESSA Pharma share dividends
We're not expecting ESSA Pharma to pay a dividend over the next 12 months.
Have ESSA Pharma's shares ever split?
ESSA Pharma's shares were split on a 1:20 basis on 24 April 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ESSA Pharma shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for ESSA Pharma shares which in turn could have impacted ESSA Pharma's share price.
ESSA Pharma share price volatility
Over the last 12 months, ESSA Pharma's shares have ranged in value from as little as $2.58 up to $11.67. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ESSA Pharma's is 1.826. This would suggest that ESSA Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ESSA Pharma overview
ESSA Pharma Inc. , a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. .
Frequently asked questions
nullWhat percentage of ESSA Pharma is owned by insiders or institutions?
Currently 2.27% of ESSA Pharma shares are held by insiders and 79.117% by institutions. How many people work for ESSA Pharma?
Latest data suggests 50 work at ESSA Pharma. When does the fiscal year end for ESSA Pharma?
ESSA Pharma's fiscal year ends in September. Where is ESSA Pharma based?
ESSA Pharma's address is: 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5 What is ESSA Pharma's ISIN number?
ESSA Pharma's international securities identification number is: CA29668H7085 What is ESSA Pharma's CUSIP number?
ESSA Pharma's Committee on Uniform Securities Identification Procedures number is: 29668H708
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question